Serratus Plane Block For Breast Reduction Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Serratus plane block was first described in 2013 by Blanco and designed to primarily block the thoracic intercostal nerves. And this block provides sufficient analgesia lateral anterior and posterior part of thoracic wall.Increased use of ultrasound guidance for regional anesthesia in recent years has led to definition of thoracic wall PECs blocks by Blanco. The Serratus plain block (SPB), providing wider analgesia, with easier application and less adverse effects than neuroaxial blocks, has been defined after these blocks and has taken its place in the literature.In spite of the insufficient randomized clinical trials in the literature, SPB has been reported for many cases such as thoracoscopy, shoulder arthroscopy, breast surgery and axillary lymph node dissections, and the results are promising. The aim of this study is to determine effectiveness of ultrasound guided bilateral serratus plane block in patients undergoing breast reduction surgery.

Main outcome measures: The primary endpoint is postoperative opioid consumption.

Secondary endpoints are visual analogue pain scores, opioid related side effects.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Erector Spinae Plane Block Versus Serratus Plane Block for Breast Surgery

NCT03538483

Postoperative Pain Breast Cancer

COMPLETED NA

IPP-PSP Block vs. SPSIPB in Breast Surgery

NCT07246720

Postoperative Acute Pain Breast Cancer Regional Anesthesia

NOT_YET_RECRUITING NA

Comparison of Serratus Plane Block and Rhomboid Intercostal Plane Block for Postoperative Analgesia in Breast Reduction Surgery

NCT07229092

Postoperative Analgesia in Breast Reduction Surgery Postoperative Pain Postoperative Pain Breast Reduction +1 more

RECRUITING NA

Serratus Posterior Superior Interfascial Plane Block for Breast Surgery

NCT05972083

Breast Diseases

COMPLETED NA

Superficial Serratus Plane Block for Modified Radical Mastectomy and Axillary Lymph Node Disection

NCT03341234

Postoperative Analgesia Pain, Postoperative Opioid Consumption

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ultrasound guided serratus plane block

Bilateral ultrasound guided serratus plane block with 30 ml %0,25 bupivacaine

Group Type ACTIVE_COMPARATOR

Bupivacaine

Intervention Type DRUG

30 ml %0,25 bupivacaine bilaterally

ultrasound guided sham block

Bilateral ultrasound guided sham block with 2 ml saline subcutaneously

Group Type PLACEBO_COMPARATOR

Saline

Intervention Type DRUG

2 ml saline subcutaneously bilaterally

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine

30 ml %0,25 bupivacaine bilaterally

Intervention Type DRUG

Saline

2 ml saline subcutaneously bilaterally

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologist's physiologic state I-III patients undergoing breast reduction surgery

Exclusion Criteria

* chronic pain
* bleeding disorders
* renal or hepatic insufficiency
* patients on chronic non-steroidal anti-inflammatory medications
* emergency cases

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No